HEATHER DETRIZIO: Open Payments
NPI 1184236218 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 91 payments from 18 companies in 2025. Trend: 2023 $797 · 2024 $2,403 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $289 |
| AstraZeneca Pharmaceuticals LP | 16 | $277 |
| Lilly USA, LLC | 11 | $204 |
| PFIZER INC. | 7 | $149 |
| Astellas Pharma US Inc | 5 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $94 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Exact Sciences Corporation | 3 | $62 |
Products named: MOUNJARO, JARDIANCE, NURTEC ODT, FARXIGA, Wegovy, Veozah, Ozempic, GEMTESA.
Industry payments across NC — which companies pay providers there.
